RankAlpha logo
Back to Rankings

BIIB

BiogenC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-23
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
BIIB vs peer average
57/100
BIIB vs. peer average (C vs. C)
Grade spread
B 1 · C 5 · D 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

REGN is the first available peer comparator.

Large-cap biotech peer with a profitable commercial portfolio and pipeline optionality; useful for comparing how BIIB is being valued through product durability plus late-stage pipeline milestones.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerREGNRegeneron
BIIB
Biogen
REGN
Regeneron
Grade
C
B
Momentum
35
28
Value
68
66
Sentiment
44
63
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs REGN

BIIB / REGN
Grade Position
In line
BIIB vs. peer average (C vs. C)
57/100
Momentum
35
BIIB
Value
68
BIIB
Sentiment
44
REGN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BIIB
1
REGN
REGN
C
60/100
Even
2
GILD
GILD
C
60/100
Even
3
AMGN
AMGN
D
40/100
+1
4
ILMN
Illumina Inc Common
C
60/100
Even
5
ZTS
Zoetis Inc Class A Common
D
40/100
+1
REGN is the first peer returned for this comparison set.